Multipurpose Prevention Technologies for Reproductive Health Symposium
Speaker Presentations
Opening Plenary 1: The Case for MPTs
The Case for Multipurpose Prevention Technologies
Scott Radloff (USAID)Do we need multipurpose prevention technologies in Kenya?
Elizabeth Bukusi (FACES)
Panel Discussion 1: The MPT Roadmap so far
Target Product Profiles for Drug-Drug and Drug-Device MPT Products
Joe Romano (MTN)The MPT Map So Far: Target Product Profiles for Multipurpose RH Vaccines
Kevin Whaley (Mapp Biopharmaceutical)
Panel Discussion 2: Pressing Issues in the Field: Hormonal Contraception and HIV Acquisition
Hormonal Contraception: Immunological Impact
Jiri Mestecky (UAB)Pressing Issues from the Field: Hormonal Contraception and HIV Acquisition
Sengeziwe Sibeko (CAPRISA)
Panel Discussion 3: Incorporating the Perspective of Product Developers & Researchers to Ensure Successful MPTs
Multipurpose Prevention Technologies: Vaccines against Sexually Transmitted Infections
Jiri Mestecky (UAB)
Panel Discussion 4: Regulatory Pathways for MPTs
DAY 2: MULTIPURPOSE PREVENTION TECHNOLOGIES: EFFICIENCIES, PARTNERSHIPS & PROMISE
Opening Plenary 2: Introduction of the first MPT: Lessons learned to Facilitate Success
Introducing the first Multipurpose Prevention Technologies: Lessons from the Past to Facilitate Success in the Future
Mitchell Warren (AVAC)Introduction of the First MPT: Lessons Learned to Facilitate the Successful Introduction of Tenofovir Gel
Sengeziwe Sibeko (CAPRISA)
Panel Discussion 1: Integrating End-User and Provider Perspectives into the Development of MPTs
Lessons Learned
Maggie Kilbourne-Brook (PATH)Incorporating End-User and Health Professional Perspectives into the Development of Multipurpose Prevention Technologies (MPTs)
Cynthia Woodsong (IPM)Socio-behavioral perspectives and MPT product profiles: the HPV vaccine experience
Vivien Tsu (PATH)
Panel Discussion 2: Donor Perspectives and the Potential for Public-Private Collaboration on MPTs
Public-Private Partnerships
Matthew Reeves (WomanCare Global)
Panel Discussion 3: Fostering Political Leadership for MPTs
